Breaking News

Lonza, Sartorius Modify Cell Culture Supply Pact

Sartorius will continue to offer Lonza products under a non-exclusive agreement

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lonza and Sartorius Stedim Biotech (SSB) have modified their current agreement for supply of cell culture media. The agreement, signed in 2012, gave SSB exclusive sales and marketing rights for certain media and buffers developed and manufactured by Lonza for use in biopharmaceutical manufacturing processes. Lonza retained sales for research-based products, among others.   Now, SSB will continue to offer current and future Lonza media and buffers on a non-exclusive basis as part of its portfol...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters